Chronic use of opioids and the endocrine system

Hormone and Metabolic Research

Volumn 42, Issue 9, 2010, Pages 621-626

  Merza, Z ^a  

^a BARNSLEY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

chronic pain; hypogonadism; opioids

Indexed keywords

BETA ENDORPHIN; CATECHOLAMINE; CHORIONIC GONADOTROPIN; CORTICOTROPIN; DIAMORPHINE; ENKEPHALIN DERIVATIVE; FENTANYL; FOLLITROPIN; GONADOTROPIN; GROWTH HORMONE; HALOTHANE; LIOTHYRONINE; LUTEINIZING HORMONE; METHADONE; MORPHINE; OXYTOCIN; PRASTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; THYROXINE; THYROXINE BINDING GLOBULIN; VASOPRESSIN;

ADRENAL INSUFFICIENCY; AMENORRHEA; BONE DENSITY; CHRONIC PAIN; DRUG DOSE REDUCTION; DRUG USE; ENDOCRINE SYSTEM; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HEROIN DEPENDENCE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPOTENCE; INSULIN METABOLISM; LIBIDO DISORDER; MENSTRUATION DISORDER; NONHUMAN; PATIENT ASSESSMENT; PRIORITY JOURNAL; SHORT SURVEY;

ANALGESICS, OPIOID; BONE DENSITY; ENDOCRINE SYSTEM; GLUCOSE; HORMONES; HUMANS; RECEPTORS, OPIOID;

EID: 77955074736     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1254099     Document Type: Short Survey

References (82)

1. Baraka A. Historical aspects of opium. MEJ Anaesthesiol 2000 15 423-436
2. Grossman A. Brain opiates and neuroendocrine function. Clin Endocrinol Metab 1983 12 725-746
3. Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem 2004 73 953-990
4. Silberstein SD, McCrory DC. Opioids. Cephalalgia 2000 20 854-864
5. Genazzani AR, Genazzani AD, Volpogni C, Pianazzi F, Li GA, Surico N, Petraglia F. Opioid control of gonadotrophin secretion in humans. Hum Reprod 1993 8 151-153
6. Howlett TA, Rees LH. Endogenous opioid peptides and hypothalamo-pituitary function. Annu Rev Physiol 1986 48 527-536
7. Mendelson JH, Mello NK, Teoh SK, Lloyd-Jones JG, Clifford JM. Naloxone suppresses buprenorphine stimulation of plasma prolactin. J Clin Psychopharmacol 1989 9 105-109
8. Cetel NS, Quigley ME, Yen SS. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids. J Clin Endocrinol Metab 1985 60 191-196
9. Steardo L, Monteleone P, Tamminga CA, Canonico PL, Denman D, Scapagnini U, Chase TN. Differential responses in prolactin levels induced by naloxone in humans. Psychoneuroendocrinology 1985 10 203-209
10. Baranowska B, Dorobek W, Misiorowski W, Jeske W, Abdel-Fattah MH. The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease. Acta Endocrinol (Copenh) 1985 110 170-175
11. Leslie RD, Prescott RW, Kendall-Taylor P, Cook D, Weightman D, Ratcliffe J, Ingram MC. Opiate receptor blockade and diurnal pituitary and adrenal hormone levels. Horm Metab Res 1985 17 86-89
12. Fontana F, Bernardi P, Pich EM, Boschi S, De Iasio R, Spampinato S, Grossi G. Opioid peptide modulation of circulatory and endocrine response to mental stress in humans. Peptides 1997 18 169-175
13. Morris M, Salmon P, Steinberg H, Sykes EA, Bouloux P, Newbould E, McLoughlin L, Besser GM, Grossman A. Endogenous opioids modulate the cardiovascular response to mental stress. Psychoneuroendocrinology 1990 15 185-192
14. Brown CH, Scott V, Ludwig M, Leng G, Bourque CW. Somatodendritic dynorphin release: orchestrating activity patterns of vasopressin neurons. Biochem Soc Trans 2007 35 1236-1242
15. Delitala G, Tomasi PA, Palermo M, Ross RJ, Grossman A, Besser GM. Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone. J Clin Endocrinol Metab 1989 69 356-358
16. Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med 2009 6 1072-1080
17. Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005 90 203-206
18. Bai J, Greenwald E, Caterini H, Kaminetzky HA. Drug-related menstrual aberrations. Obstet Gynecol 1974 44 713-719
19. Facchinetti F, Volpe A, Farci G, Petraglia F, Porro CA, Barbieri G, Cioni A, Balestrieri A, Genazzani AR. Hypothalamus-pituitary-adrenal axis of heroin addicts. Drug Alcohol Depend 1985 15 361-366
20. Azizi F, Vagenakis AG, Longcope C, Ingbar SH, Braverman LE. Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 1973 22 467-472
21. Wang C, Chan V, Yeung RT. The effect of heroin addiction on pituitary-testicular function. Clin Endocrinol (Oxf) 1978 9 455-461 (Pubitemid 9068761)
22. Ragni G, De Lauretis L, Bestetti O, Sghedoni D, Gambaro V. Gonadal function in male heroin and methadone addicts. Int J Androl 1988 11 93-100
23. Moshtaghi-Kashanian GR, Esmaeeli F, Dabiri S. Enhanced prolactin levels in opium smokers. Addict Biol 2005 10 345-349
24. Bolelli G, Lafisca S, Flamigni C, Lodi S, Franceschetti F, Filicori M, Mosca R. Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroin. Toxicology 1979 15 19-29
25. Lafisca S, Bolelli G, Franceschetti F, Danieli A, Tagliaro F, Marigo M, Flamigni C. Free and bound testosterone in male heroin addicts. Arch Toxicol Suppl 1985 8 394-397
26. Celani MF, Carani C, Montanini V, Baraghini GF, Zini D, Simoni M, Ferretti C, Marrama P. Further studies on the effects of heroin addiction on the hypothalamic-pituitary-gonadal function in man. Pharmacol Res Commun 1984 16 1193-1203
27. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002 3 377-384
28. Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008 9 28-36
29. Daniell HW. DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. J Pain 2006 7 901-907
30. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000 85 2215-2222
31. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004 100 851-858
32. Roberts LJ, Finch PM, Pullan PT, Bhagat CI, Price LM. Sex hormone suppression by intrathecal opioids: a prospective study. Clin J Pain 2002 18 144-148
33. Behar M, Magora F, Olshwang D, Davidson JT. Epidural morphine in treatment of pain. Lancet 1979 1 8115 527-529 (Pubitemid 9130910)
34. Doleys DM, Dinoff BL, Page L, Tutak U, Willis KD, Coleton M. Sexual dysfunction and other side effects of intraspinal opiate use in the management of chronic non-cancer pain. AJPM 1998 8 5-11
35. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994 9 126-131
36. Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000 16 251-254
37. Adams ML, Sewing B, Forman JB, Meyer ER, Cicero TJ. Opioid-induced suppression of rat testicular function. J Pharmacol Exp Ther 1993 266 323-328
38. Dackis CA, Gurpegui M, Pottash AL, Gold MS. Methadone induced hypoadrenalism. Lancet 1982 2 8308 1167
39. Pullan PT, Watson FE, Seow SS, Rappeport W. Methadone-induced hypoadrenalism. Lancet 1983 1 8326 714
40. Cam J, Gilabert M, San L, de la Torre R. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Br J Addict 1992 87 1145-1151
41. Merza Z, Edwards N, Walters SJ, Newell-Price J, Ross RJ. Patients with chronic pain and abnormal pituitary function require investigation. Lancet 2003 361 9376 2203-2204
42. Oltmanns KM, Fehm HL, Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 2005 257 478-480
43. Mussig K, Knaus-Dittmann D, Schmidt H, Morike K, Haring HU. Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment. Clin Endocrinol (Oxf) 2007 66 604-605
44. Hall GM, Lacoumenta S, Hart GR, Burrin JM. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. Br J Anaesth 1990 65 251-253
45. Lacoumenta S, Yeo TH, Burrin JM, Bloom SR, Paterson JL, Hall GM. Fentanyl and the beta-endorphin, ACTH and glucoregulatory hormonal response to surgery. Br J Anaesth 1987 59 713-720 (Pubitemid 17113299)
46. English TN, Ruxton D, Eastman CJ. Abnormalities in thyroid function associated with chronic therapy with methadone. Clin Chem 1988 34 2202-2204
47. Chan V, Wang C, Yeung RT. Effects of heroin addiction on thyrotrophin, thyroid hormones and porlactin secretion in men. Clin Endocrinol (Oxf) 1979 10 557-565
48. Webster JB, Coupal JJ, Cushman P Jr. Increased serum thyroxine levels in euthyroid narcotic addicts. J Clin Endocrinol Metab 1973 37 928-934
49. Brambilla F, Nobile P, Zanoboni A, Zanoboni-Muciaccia W, Meroni PL. Effects of chronic heroin addiction on pituitary-thyroid function in man. J Endocrinol Invest 1980 3 251-255
50. Spagnolli W, De Venuto G, Mattarei M, Dal Ri P, Miori R. Prolactin and thyrotropin pituitary response to thyrotropin releasing hormone in young female heroin addicts. Drug Alcohol Depend 1987 20 247-254
51. Shenkman L, Massie B, Mitsuma T, Hollander CS. Effects of chronic methadone administration on the hypothalamic-pituitary-thyroid axis. J Clin Endocrinol Metab 1972 35 169-170
52. Pende A, Musso NR, Montaldi ML, Pastorino G, Arzese M, Devilla L. Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. Biomed Pharmacother 1986 40 178-182
53. Roti E, Degli Uberti E, Salvadori S, Bianconi M, Emanuele R, Rotola C, Trasforini G, Robuschi G, Tomatis R, Gnudi A, Pansini R, Braverman LE. Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects. J Endocrinol Invest 1984 7 211-214
54. Delitala G, Grossman A, Besser M. Differential effects of opioid peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology 1983 37 275-279
55. Cushman P Jr. Growth hormone in narcotic addiction. J Clin Endocrinol Metab 1972 35 352-358
56. Volpi R, Gerra G, Vourna S, Vescovi PP, Maestri D, Chiodera P, Coiro V. Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in heroin addicts. Life Science 1992 51 247-251
57. Delitala G, Tomasi PA, Palermo M, Ross RJ, Grossman A, Besser GM. Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone. J Clin Endocrinol Metab 1989 69 356-358
58. Grossman A, Besser GM, Milles JJ, Baylis PH. Inhibition of vasopressin release in man by an opiate peptide. Lancet 1980 2 8204 1108-1110
59. Brownell J, del Pozo E, Donatsch P. Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans. Acta Endocrinol (Copenh) 1980 94 304-308
60. Zerbe RL, Henry DP, Robertson GL. A new metenkephalin analogue suppresses plasma vasopressin in man. Peptides 1982 3 199-201
61. Lindow SW, van der Spuy ZM, Hendricks MS, Nugent FA, Dunne TT. The effect of morphine and naloxone administration on maternal oxytocin concentration in late pregnancy. Clin Endocrinol (Oxf) 1993 39 671-675
62. Lindow SW, van der Spuy ZM, Hendricks MS, Rosselli AP, Lombard C, Leng G. The effect of morphine and naloxone administration on plasma oxytocin concentrations in the first stage of labour. Clin Endocrinol (Oxf) 1992 37 349-353
63. Lindow SW, Hendricks MS, Nugent FA, Dunne TT, van der Spuy ZM. Morphine suppresses the oxytocin response in breast-feeding women. Gynecol Obstet Invest 1999 48 33-37
64. De Leon-Jones FA, Davis JM, Inwang EE, Dekirmenjian H. Excretion of catecholamine metabolites during methadone maintenance and withdrawal. Arch Gen Psychiatry 1983 40 841-847
65. Hoehe M, Duka T. Opiates increase plasma catecholamines in humans. Psychoneuroendocrinology 1993 18 141-148
66. Prez-Castrilln JL, Olmos JM, Gmez JJ, Barrallo A, Riancho JA, Perera L, Valero C, Amado JA, Gonzlez-Macas J. Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 2000 72 187-194
67. Rosen H, Krichevsky A, Bar-Shavit Z. The enkephalinergic osteoblast. J Bone Miner Res 1998 13 1515-1520
68. Rico H, Costales C, Cabranes JA, Escudero M. Lower serum osteocalcin levels in pregnant drug users and their newborns at the time of delivery. Obstet Gynecol 1990 75 998-1000
69. Elhassan AM, Lindgren JU, Hultenby K, Bergstrom J, Adem A. Methionine-enkephalin in bone and joint tissues. J Bone Miner Res 1998 13 88-95
70. Kim TW, Alford DP, Malabanan A, Holick MF, Samet JH. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 2006 85 258-262
71. Pedrazzoni M, Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, Alfano FS, Passeri M. Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 1993 129 42-45
72. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med 2006 260 76-87
73. Brambilla F, Guerrini A, Guastalla A, Beretta P, Maio DD. Glucose-insulin metabolism in herion addicts. Neuropsychobiology 1976 2 341-349
74. Reed JL, Ghodse AH. Oral glucose tolerance and hormonal response in heroin-dependent males. Br Med J 1973 2 5866 582-585
75. Passariello N, Giugliano D, Ceriello A, Chiariello A, Sgambato S, DOnofrio F. Impaired insulin response to glucose but not to arginine in heroin addicts. J Endocrinol Invest 1986 9 353-357
76. Ceriello A, Giugliano D, Dello Russo P, Sgambato S, DOnofrio F. Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. Diabetologia 1982 22 379
77. Sadava D, Alonso D, Hong H, Pettit-Barrett DP. Effect of methadone addiction on glucose metabolism in rats. Gen Pharmacol 1997 28 27-29 (Pubitemid 27016055)
78. Beswick T, Best D, Rees S, Coomber R, Gossop M, Strang J. Multiple drug use: patterns and practices of heroin and crack use in a population of opiate addicts in treatment. Drug Alcohol Rev 2001 20 201-204
79. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000 343 1290-1297
80. Lawlor PG, Turner KS, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer 1998 82 1167-1173
81. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998 129 229-240
82. Frisch RE. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynaecol 1990 4 419-439